Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lowes | LOW | Nov 20, 2024 | 263.03 | +1.45 |
LPL Financial | LPLA | Nov 20, 2024 | 317.05 | +0.80 |
LQR House | LQR | Nov 20, 2024 | 1.28 | +4.92 |
LSB Industries | LXU | Nov 20, 2024 | 8.51 | +1.19 |
LSI Industries | LYTS | Nov 20, 2024 | 20.02 | -1.23 |
Ltc Properties | LTC | Nov 20, 2024 | 38.37 | -0.52 |
Lucas GC | LGCL | Nov 20, 2024 | 1.00 | -3.94 |
Lucid Diagnostics | LUCD | Nov 20, 2024 | 1.00 | +4.62 |
Lucid Group | LCID | Nov 20, 2024 | 2.03 | -3.33 |
Lufax ADR | LU | Nov 20, 2024 | 2.41 | +0.42 |
Lululemon Athletica | LULU | Nov 20, 2024 | 308.31 | +2.14 |
Lulus Fashion Lounge | LVLU | Nov 20, 2024 | 1.26 | 0.00 |
Lumen Technologies | LUMN | Nov 20, 2024 | 7.55 | -2.45 |
Lument Finance Trust | LFT | Nov 20, 2024 | 2.55 | -0.78 |
Lument Finance Trust A Pref | LFT-A | Nov 20, 2024 | 22.52 | 0.00 |
Lumentum | LITE | Nov 20, 2024 | 82.47 | -0.01 |
Luminar Technologies A | LAZR | Nov 20, 2024 | 0.76 | -5.09 |
Lumos Pharma | LUMO | Nov 20, 2024 | 4.32 | -0.23 |
Luna Innovations | LUNA | Nov 20, 2024 | 1.63 | -0.61 |
Luokung Technology | LKCO | Nov 20, 2024 | 1.70 | +5.59 |
Luxfer | LXFR | Nov 20, 2024 | 14.08 | -2.56 |
LuxUrban Hotels | LUXH | Nov 20, 2024 | 1.52 | +5 309.25 |
Luxurban Hotels Pref | LUXHP | Nov 20, 2024 | 15.37 | -10.64 |
Lxp Industrial Trust | LXP | Nov 20, 2024 | 9.18 | +0.11 |
LXP Industrial Trust C Pref | LXP-C | Nov 20, 2024 | 50.12 | -1.05 |
Lyell Immunopharma | LYEL | Nov 20, 2024 | 1.03 | -7.21 |
Lyft A | LYFT | Nov 20, 2024 | 16.77 | +1.21 |
LyondellBasell Industries Nv A | LYB | Nov 20, 2024 | 82.48 | +0.34 |
Lyra Therapeutics | LYRA | Nov 20, 2024 | 0.18 | -9.04 |
Lytus Technologies | LYT | Nov 20, 2024 | 1.60 | -0.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.